Truist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $9.5

Benzinga · 03/13 14:45
Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $10 to $9.5.